Clinical and angiographic outcomes after treatment of de novo coronary stenoses with a novel platinum chromium thin-strut stent: Primary results of the PERSEUS (prospective evaluation in a randomized trial of the safety and efficacy of the use of the TAXUS element paclitaxel-eluting coronary stent system) trial

Journal of the American College of Cardiology

Volumn 56, Issue 4, 2010, Pages 264-271

  Kereiakes, Dean J ^a   Cannon, Louis A ^b   Feldman, Robert L ^c   Popma, Jeffrey J ^d   Magorien, Raymond ^e   Whitbourn, Robert ^f   Dauber, Ira M ^g   Rabinowitz, Abram C ^h   Ball, Michael W ⁱ   Bertolet, Barry ^j   Kabour, Ameer ^k   Foster, Michael C ^l   Wang, John C ^m   Underwood, Paul ⁿ   Dawkins, Keith D ⁿ  

^a CHRIST HOSPITAL   (United States)

^b Northern Michigan Regional Hospital   (United States)

^c Munroe Regional Med Center   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^f ST VINCENT S HOSPITAL   (Australia)

^g HealthOne   (United States)

^h Department of Emergency Medicine   (United States)

ⁱ ST VINCENT HOSPITAL   (United States)

^j NORTH MISSISSIPPI MEDICAL CENTER   (United States)

^k ST VINCENT MERCY MEDICAL CENTER   (United States)

^l Sisters of Charity Providence Hospitals   (United States)

^m UNION MEMORIAL HOSPITAL   (United States)

ⁿ BOSTON SCIENTIFIC CORPORATION   (United States)

more..

Author keywords

chromium; drug eluting stent; paclitaxel; platinum; restenosis

Indexed keywords

'TAXUS'; ACETYLSALICYLIC ACID; CHROMIUM; PACLITAXEL; PLATINUM; THIENOPYRIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; ARTERY DIAMETER; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MATERIAL COATING; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; SINGLE BLIND PROCEDURE; STENT THROMBOSIS; TARGET LESION FAILURE; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME;

AGED; CHROMIUM; CHROMIUM ALLOYS; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; PLATINUM; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 77955661056     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.04.011     Document Type: Article

References (22)

1. S.G. Ellis, G.W. Stone, and D.A. Cox, et al. Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent) J Am Coll Cardiol Intv 2 2009 1248 1259
2. G.W. Stone, S.G. Ellis, and D.A. Cox, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 350 2004 221 231
3. M.A. Turco, J.A. Ormiston, and J.J. Popma, et al. Polymer-based, paclitaxel-eluting TAXUS Liberte stent in de novo lesions: the pivotal TAXUS ATLAS Trial J Am Coll Cardiol 49 2007 1676 1683
4. J.M. Lasala, D.A. Cox, and S.J. Lewis, et al. Expanded use of the TAXUS Express stent: 2-year insights on safety from the 7500 patient ARRIVE Registry Programme EuroIntervention 5 2009 67 77
5. P.W. Serruys, M.C. Morice, and A.P. Kappetein, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease N Engl J Med 360 2009 961 972
6. G.W. Stone, S.G. Ellis, and L. Cannon, et al. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial JAMA 294 2005 1215 1223
7. E. Mahmud, J.A. Ormiston, and M.A. Turco, et al. TAXUS Liberté attenuates the risk of restenosis in patients with medically treated diabetes mellitus: results from the TAXUS ATLAS program J Am Coll Cardiol Intv 2 2009 240 252
8. B.J. O'Brien, J.S. Stinson, S.R. Larsen, M.J. Eppihimer, and W.M. Carroll A platinum-chromium steel for cardiovascular stents Biomaterials 31 2010 3755 3761
9. R. Steiner ASM Handbook Volume 1: Properties and Selection: Irons, Steels, and High-Performance Alloys 10th edition 1990 ASM International Materials Park, OH
10. G.J. Wilson, B.A. Huibregtse, and E.A. Stejskal, et al. Vascular response to a third generation everolimus-eluting stent EuroIntervention 2010 In press
11. D.J. Allocco, L.A. Cannon, and A. Britt, et al. A prospective evaluation of the safety and efficacy of the TAXUS Element paclitaxel-eluting coronary stent system for the treatment of de novo coronary artery lesions: design and statistical methods of the PERSEUS clinical program Trials 11 2010 1
12. N.V. Soucy, J.M. Feygin, and R. Tunstall, et al. Strut coverage and endothelial cell recovery: a comparison between bare metal stent platforms and stents with and without drug-eluting coating (abstr) EuroIntervention 2010 In press
13. S.B. King III, S.C. Smith Jr., and J.W. Hirshfeld Jr., et al. 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (2007 Writing Group to Review New Evidence and Update the 2005 ACC/AHA/SCAI Guideline Update for Percutaneous Coronary Intervention) J Am Coll Cardiol 51 2008 172 209
14. M.A. Turco, J.A. Ormiston, and J.J. Popma, et al. Reduced risk of restenosis in small vessels and reduced risk of myocardial infarction in long lesions with the new thin-strut TAXUS Liberté stent: 1-year results from the TAXUS ATLAS program J Am Coll Cardiol Intv 1 2008 699 709
15. Guidance for the Use of Bayesian Statistics in Medical Device Clinical Trials. U.S. Food and Drug Administration, Center for Devices and Radiological Health. Available at: http://www.fda.gov/MedicalDevices/ DeviceRegulationandGuidance/GuidanceDocuments/ucm071072.htm. Accessed February 5, 2010
16. G. Nakazawa, A.V. Finn, and M. Vorpahl, et al. Incidence and predictors of drug-eluting stent fracture in human coronary artery a pathologic analysis J Am Coll Cardiol 54 2009 1924 1931
17. D.E. Cutlip, S. Windecker, and R. Mehran, et al. Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
18. S. Kaul, and G.A. Diamond Trial and error: how to avoid commonly encountered limitations of published clinical trials J Am Coll Cardiol 55 2010 415 427
19. J. Pache, A. Kastrati, and J. Mehilli, et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial J Am Coll Cardiol 41 2003 1283 1288
20. A. Kastrati, J. Mehilli, and J. Dirschinger, et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial Circulation 103 2001 2816 2821
21. G.W. Stone, A. Rizvi, and W. Newman, et al. Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease N Engl J Med 362 2010 1663 1674
22. M.B. Leon, L. Mauri, and J.J. Popma, et al. A randomized comparison of the endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial J Am Coll Cardiol 55 2010 543 554